Name
D2A2 - Cancer
Date & Time
Tuesday, May 27, 2025, 3:30 PM - 5:30 PM
Location Name
Hall A
Description

3:30 pm - 3:35 pm
Chair: Landon Edgar

3:35 pm - 4:10 pm
Keynote Speaker: Dr. Jennifer Munkley
Harnessing the power of glycans to revolutionise the diagnosis and treatment of prostate cancer.
Click here to read abstract

4:10 pm - 4:35 pm
Invited Speaker: Dr. Heinz Läubli
Enhancing Cancer Immunotherapy by Targeting Cancer-Associated Glycans
Click here to read abstract

4:35 pm - 5:00 pm
Invited Speaker: Dr. Kelly McNagny
PODXL as a broad-spectrum therapeutic target for poor outcome tumors
Click here to read abstract

5:00 pm - 5:15 pm
Oral Abstract: Mathieu Decloquement
Deciphering Siglec ligands in cancer to improve immunotherapy
Click here to read abstract

5:15 pm - 5:30 pm
Oral Abstract: Rita Nehmé
Development of Galectin-7 and Galectin-1-Specific Inhibitors: Immunotherapy and Molecular Imaging in Triple-Negative Breast Cancer
Click here to read abstract

Jennifer Munkley Heinz Läubli Kelly McNagny